New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
12:15 EDTBAXBaxter spin-off brings 15%-25% potential upside, says Piper Jaffray
Piper Jaffray estimates the potential equity value for Baxter's two businesses around $45B-$50B, which it notes represents upside of between 15%-25% from share current levels. Piper says it remains bullish on Baxter after the company announced the spin-off of its BioScience division. It reiterates an Overweight rating on Baxter with an $82 price target.
News For BAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 23, 2015
09:08 EDTBAXBaxter announces Illinois headquarters for biopharmaceutical spin-off
Subscribe for More Information
February 20, 2015
07:08 EDTBAXAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 19, 2015
18:25 EDTBAXPiper Jaffray biotech analyst to hold analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use